Market Overview:
Southern blotting is a molecular biology technique used to detect the presence of a specific DNA sequence in DNA samples. It relies on the transfer of agarose gel resolved DNA fragments to a membrane, followed by overnight hybridization of a labeled probe to its complementary target fragment on the membrane. The labeled probe-target fragment hybrid is then detected using chemiluminescent or radiographic techniques. Southern blotting is widely used in genomics research for genotyping and identification of pathogens. It allows rapid and sensitive detection of DNA fragments from complex mixtures.
The global Southern Blotting Market is estimated to be valued at US$ 2.8 Bn in 2023 and is expected to exhibit a CAGR of 5.2% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
Increasing research activities focused on genomics is a major factor driving growth of the southern blotting market. For instance, according to The Global Alliance for Genomics and Health, research institutions worldwide spent over US$ 10 billion on genome sequencing projects in 2019 alone. Southern blotting finds wide application in human genome sequencing research for identification of gene mutations. Additionally, rising prevalence of genetic disorders and increased funding for precision medicine is also boosting adoption of southern blotting techniques. Furthermore, ongoing technological advancements such as development of advanced detection systems for sensitive detection of probes are estimated to support market growth over the forecast period. However, availability of newer techniques such as polymerase chain reaction (PCR) and next generation sequencing poses potential threats to the market.
Porter’s Analysis
Threat of new entrants: The Southern Blotting market requires huge capital investment for research and development, which poses high entry barriers for new players. Bargaining power of buyers: Buyers have moderate bargaining power due to availability of substitutes. However, customized product requirement maintains buyers’ dependency on existing market players. Bargaining power of suppliers: Major players dominate the market and have significant control over the prices of antibodies and reagents, exerting high influence. Threat of new substitutes: Alternatives like Polymerase Chain Reaction (PCR) offer convenience but lack sensitivity for rare transcripts, limiting impact of new substitutes. Competitive rivalry: The presence of established players has led to intense competition.
SWOT Analysis
Strength: Thermal Fisher Scientific, Merck KGaA and Danaher Corporation have leading R&D capabilities and product portfolios.
Weakness: High costs associated withSouthern blotting reduce its adoption, especially in cost-sensitive regions.
Opportunity: Increasing applications in gene expression, molecular biology and genomics offer scope.
Threats: Alternatetechniques such as PCRand microarrays that provide faster results pose major threat.
Key Takeaways
The global Southern Blotting Market Growth is expected to witness high growth, exhibiting CAGR of 5.2% over the forecast period, due to increasing number of genomics projects to support discoveries.
Regional analysis North America will continue dominating the Southern blotting market due to concentrated presence of international companies and availability of resources. Asia Pacific is poised to grow at fastest pace owing to rising investment in personalized medicine and biotechnology research.
Key players operating in the Southern blotting market are Thermo Fisher Scientific, Merck KGaA, Danaher Corporation, Agilent Technologies, PerkinElmer, GE Healthcare, Promega Corporation, Genetec, Bio-Rad Laboratories, Abcam.
For more details on the report, Read- https://www.pressreleasebulletin.com/southern-blotting-market-trends-size-and-share-analysis/
